Jesús Duque-Afonso

33PUBLICATIONS
124CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 10, 2026
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

|Sep 05, 2026
Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

|Mar 06, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Laura Polcik, Abhishek Pethe, Driti Ashok

|Jul 09, 2025
Genomic determinants of therapy response in ETV6::RUNX1 leukemia.

Laura Oksa, Sanni Moisio, Khurram Maqbool

|Feb 04, 2025
Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure.

Mira Kusterer, Mari Lahnalampi, Minna Voutilainen

|Dec 20, 2024
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.

Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya

Pageof 6

Frequent Collaborators

11 joint publications

Robert Zeiser

9 joint publications

Ralph Wäsch

8 joint publications

Jürgen Finke

6 joint publications

Gabriele Ihorst